Brainstorm Cell Therapeutics UK Ltd - Dormant accounts - members and to registrar (filleted) 21.1

Brainstorm Cell Therapeutics UK Ltd - Dormant accounts - members and to registrar (filleted) 21.1

BRAINSTORM CELL THERAPEUTICS UK LTD - Company Information

Print Friendly Version

IRIS Accounts Production v22.1.0.628 08410584 director 1.3.21 28.2.22 28.2.22 No description of principal activity 0 0 false true false false true true iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure084105842021-02-28084105842022-02-28084105842021-03-012022-02-28084105842020-02-28084105842020-02-292021-02-28084105842021-02-2808410584ns16:EnglandWales2021-03-012022-02-2808410584ns15:PoundSterling2021-03-012022-02-2808410584ns11:Director12021-03-012022-02-2808410584ns11:PrivateLimitedCompanyLtd2021-03-012022-02-2808410584ns11:SmallEntities2021-03-012022-02-2808410584ns11:AuditExempt-NoAccountantsReport2021-03-012022-02-2808410584ns11:SmallCompaniesRegimeForDirectorsReport2021-03-012022-02-2808410584ns11:SmallCompaniesRegimeForAccounts2021-03-012022-02-2808410584ns11:AbbreviatedAccounts2021-03-012022-02-2808410584ns11:CompanySecretary12021-03-012022-02-2808410584ns11:RegisteredOffice2021-03-012022-02-2808410584ns6:ShareCapital2022-02-2808410584ns6:ShareCapital2021-02-28
REGISTERED NUMBER: 08410584 (England and Wales)










UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 28 FEBRUARY 2022

FOR

BRAINSTORM CELL THERAPEUTICS UK LTD
Vistra Trust Company Limited
First Floor, Templeback
10 Temple back
Bristol
BS1 6FL








BRAINSTORM CELL THERAPEUTICS UK LTD (REGISTERED NUMBER: 08410584)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2022




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3
BRAINSTORM CELL THERAPEUTICS UK LTD


COMPANY INFORMATION
FOR THE YEAR ENDED 28 FEBRUARY 2022







Director: Uri Yablonka





Secretary: Vistra Company Secretaries Limited





Registered office: Suite 1, 3rd Floor
11-12 St James Square
London
SW1Y 4LB





Registered number: 08410584 (England and Wales)
Page 1
BRAINSTORM CELL THERAPEUTICS UK LTD (REGISTERED NUMBER: 08410584)


BALANCE SHEET
28 FEBRUARY 2022

28.2.22 28.2.21
£    £   
CURRENT ASSETS
Cash in hand 100 100
TOTAL ASSETS LESS CURRENT
LIABILITIES
100
100

CAPITAL AND RESERVES
Called up share capital 100 100
100 100

The company is entitled to exemption from audit under Section 480 of the Companies Act 2006 for the year ended 28 February 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 29 November 2022 and were signed by:





Uri Yablonka - Director


The notes form part of these financial statements

Page 2
BRAINSTORM CELL THERAPEUTICS UK LTD (REGISTERED NUMBER: 08410584)


NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2022

1. STATUTORY INFORMATION

Brainstorm Cell Therapeutics UK Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into.

Basic financial liabilities
Basic financial liabilities, including creditors, and loans from fellow group companies are initially recognised at transaction price.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are initially recognised at transaction price.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2021 - NIL).

Page 3